10-Q - CRYO CELL INTERNATIONAL INC (0000862692) (Filer)

Mon, Apr 14, 9:01 PM (15 days ago)

**Cryo-Cell International, Inc. (CCEL) Q1 2025 Financial Summary** **Financial Health & Performance:** - **Revenue:** $7,968,880 (up 2% YoY) - Processing & Storage Fees: $7,865,888 (up 1% YoY) - Product Revenue: $20,913 (up 637% YoY) - Public Cord Blood Banking Revenue: $82,079 (up 85% YoY) - **Profit Margins:** Operating Income: $1,056,011 (up 28% YoY) - **Cash Flow:** Net Cash from Operating Activities: $954,063 (up 166% YoY) - **Earnings Changes:** Net Income: $282,855 (down 49% YoY) - **Cash & Cash Equivalents:** $223,122 (down 60% QoQ) **Quarterly Performance Discussion:** - **Revenue Growth:** Driven by a 4% increase in recurring annual storage fees, offset by a 12% decrease in new domestic cord blood specimens processed. - **Cost Management:** Cost of sales decreased by 4%, primarily due to reduced processing and quality system enhancements. - **Operational Efficiency:** Selling, general, and administrative expenses increased by 5%, mainly due to higher selling and marketing expenses. - **Investment & Financing:** The company utilized its revolving line of credit and paid a cash dividend of $0.25 per share. **Trends & Uncertainties:** - **Market Penetration:** The company aims to increase market awareness and penetration of its cord blood stem cell preservation services. - **Legal & Regulatory:** The company is involved in legal proceedings and faces uncertainties related to its Duke License Agreement. - **Future Operations Impact:** The company's future success depends on its ability to expand its business units and manage regulatory and competitive challenges. **Future Outlook:** - The company anticipates that its cash and cash equivalents, marketable securities, and cash flows from operations, together with external sources of capital, will be sufficient to fund its known cash needs for at least the next 12 months. - However, the outcome of the Duke Arbitration Demand and other legal proceedings may impact the company's funding needs and strategic initiatives.